Einzeltreffer — DigiBib

Purpose: Despite widely available safety information for the COVID-19 vaccines, vaccine hesitancy remains a challenge. In some cases, vaccine hesitancy may be related to concerns about the number of reports of death to the Vaccine Adverse Event Reporting System (VAERS). We aimed to provide information and context about reports of death to VAERS following COVID-19 vaccination.

Methods: This is a descriptive study evaluating reporting rates for VAERS death reports for COVID-19 vaccine recipients in the United States between December 14, 2020, and November 17, 2021. Reporting rates were calculated as death events per million persons vaccinated and compared to expected all-cause (background) death rates.

Results: 9201 death events were reported for COVID-19 vaccine recipients aged 5 years and older (or age unknown). Reporting rates for death events increased with increasing age, and males generally had higher reporting rates than females. For death events within 7 days and 42 days of vaccination, respectively, observed reporting rates were lower than the expected all-cause death rates. Reporting rates for Ad26.COV2.S vaccine were generally higher than for mRNA COVID-19 vaccines, but still lower than the expected all-cause death rates. Limitations of VAERS data include potential reporting bias, missing or inaccurate information, lack of a control group, and reported diagnoses, including deaths, are not causally verified diagnoses.

Conclusions: Reporting rates for death events were lower than the all-cause death rates expected in the general population. Trends in reporting rates reflected known trends in background death rates. These findings do not suggest an association between vaccination and overall increased mortality.

Titel:	Reporting rates for VAERS death reports following COVID-19 vaccination, December 14, 2020-November 17, 2021.
Autor/in / Beteiligte Person:	Day, B ; Menschik, D ; Thompson, D ; Jankosky, C ; Su, J ; Moro, P ; Zinderman, C ; Welsh, K ; Dimova, RB ; Nair, N
Link:	Full Text Finder (Volltext)
Zeitschrift:	Pharmacoepidemiology and drug safety, Jg. 32 (2023-07-01), Heft 7, S. 763-772
Veröffentlichung:	Chichester, West Sussex : Wiley, 1992-, 2023
Medientyp:	academicJournal
ISSN:	1099-1557 (electronic)
DOI:	10.1002/pds.5605
Schlagwort:	Female Humans Male Ad26COVS1 Adverse Drug Reaction Reporting Systems United States epidemiology Vaccination adverse effects COVID-19 epidemiology COVID-19 prevention & control COVID-19 Vaccines adverse effects Vaccines adverse effects
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Publication Type: Journal Article Language: English [Pharmacoepidemiol Drug Saf] 2023 Jul; Vol. 32 (7), pp. 763-772. <i>Date of Electronic Publication: </i>2023 Mar 07. MeSH Terms: COVID-19* / epidemiology ; COVID-19* / prevention & control ; COVID-19 Vaccines* / adverse effects ; Vaccines* / adverse effects ; Female ; Humans ; Male ; Ad26COVS1 ; Adverse Drug Reaction Reporting Systems ; United States / epidemiology ; Vaccination / adverse effects References: Centers for Disease Control and Prevention. COVID Data Tracker: United States COVID-19 Cases, Deaths, and Laboratory Testing (NAATs) by State, Territory, and Jurisdiction. 2021. https://covid.cdc.gov/covid-data-tracker/#cases_totalcases. ; Centers for Disease Control and Prevention. COVID-19 Vaccination Demographics in the United States, National. 2021. https://data.cdc.gov/Vaccinations/COVID-19-Vaccination-Demographics-in-the-United-St/km4m-vcsb. ; Holtkamp N, Kolbe AK, Beleche T. COVID-19 Vaccination Associated with Reductions in COVID-19 Mortality and Morbidity in the United States, and an Approach to Valuing these Benefits: Office of the Assistant Secretary for Planning and Evaluation. 2021. https://aspe.hhs.gov/reports/economic-health-benefits-covid-19-vaccination. ; Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245-251. doi:10.1016/j.puhe.2021.02.025. ; Wagner B. Fact Check: Vaccine Adverse Reporting System Isn't Proof of COVID-19 Vaccine Deaths. USA Today; 2021. https://www.usatoday.com/story/news/factcheck/2021/06/28/fact-check-covid-19-vaers-death-reports-not-verified/7587577002/. ; Reuters Fact Check. Fact Check-VAERS Data Does Not Suggest COVID-19 Vaccines Killed 150,000 People, As Analysis Claims. Reuters; 2021. https://www.reuters.com/article/factcheck-coronavirus-usa/fact-check-vaers-data-does-not-suggest-covid-19-vaccines-killed-150000-people-as-analysis-claims-idUSL1N2R00KP. ; Jaramillo C. Viral Posts Misuse VAERS Data to Make False Claims About COVID-19 Vaccines. FactCheck.org; 2021. https://www.factcheck.org/2021/03/scicheck-viral-posts-misuse-vaers-data-to-make-false-claims-about-covid-19-vaccines/. ; Kertscher T. No Truth That VAERS System Shows 6,000 “Died Because of” COVID-19 Vaccines. Politifact - The Poynter Institute; 2021. https://www.politifact.com/factchecks/2021/aug/09/tiktok-posts/no-truth-vaers-system-shows-6000-died-because-covi/. ; US Food and Drug Administration. Vaccine Adverse Event Reporting System (VAERS) Questions and Answers. 2021. https://www.fda.gov/vaccines-blood-biologics/vaccine-adverse-events/vaccine-adverse-event-reporting-system-vaers-questions-and-answers. ; Centers for Disease Control and Prevention. Vaccine Safety: Vaccine Adverse Event Reporting System (VAERS). 2021. https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html#anchor_1616772579977. ; Centers for Disease Control and Prevention. CDC WONDER: Vaccine Adverse Event Reporting Systems (VAERS). 2021. https://wonder.cdc.gov/wonder/help/vaers.html. ; US Department of Health and Human Services. VAERS Home: Frequently Asked Questions (FAQs). 2021. https://vaers.hhs.gov/faq.html. ; US Department of Health and Human Services. Guide to Interpreting VAERS Data. 2021. https://vaers.hhs.gov/data/dataguide.html. ; Centers for Disease Control and Prevention. CDC COVID-19 Vaccination Program Provider Requirements and Support 2022. 2022. https://www.cdc.gov/vaccines/covid-19/vaccination-provider-support.html. ; US Food and Drug Administration. Janssen COVID-19 Vaccine: Fact Sheet for Healthcare Providers Administering Vaccine 2022. 2022. https://www.fda.gov/media/146304/download. ; US Food and Drug Administration. Moderna COVID-19 Vaccine: Fact Sheet for Healthcare Providers Administering Vaccine 2022. 2022. https://www.fda.gov/media/144637/download. ; US Food and Drug Administration. Pfizer-BioNTech COVID-19 Vaccine: Fact Sheet for Healthcare Providers Administering Vaccine 2022. 2022. https://www.fda.gov/media/153713/download. ; Shimabukuro T, Nguyen M, Martin D, DeStefano F. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2015;33(36):4398-4405. doi:10.1016/j.vaccine.2015.07.035. ; US Department of Health and Human Services. Report an Adverse Event with a Writable PDF Form 2021. 2021. https://vaers.hhs.gov/uploadFile/index.jsp. ; Centers for Disease Control and Prevention. Vaccine Adverse Event Reporting System (VAERS) Standard Operating Procedures for COVID-19 (as of 29 January 2021). 2021. https://www.cdc.gov/vaccinesafety/pdf/VAERS-v2-SOP.pdf. ; US Department of Health and Human Services. VAERS Table of Reportable Events Following Vaccination 2017. 2021. https://vaers.hhs.gov/docs/VAERS_Table_of_Reportable_Events_Following_Vaccination.pdf. ; Centers for Disease Control and Prevention. Understanding the Vaccine Adverse Event Reporting System (VAERS) 2013. 2021. https://www.cdc.gov/vaccines/hcp/patient-ed/conversations/downloads/vacsafe-vaers-color-office.pdf. ; Abara WE, Gee J, Delorey M, et al. Expected rates of select adverse events after immunization for coronavirus disease 2019 vaccine safety monitoring. J Infect Dis. 2022;225(9):1569-1574. doi:10.1093/infdis/jiab628. ; Centers for Disease Control and Prevention. CDC WONDER: Multiple Cause of Death 1999-2020. 2022. https://wonder.cdc.gov/wonder/help/mcd.html. ; VAC4EU. COVID-19 vaccine monitoring 2019. 2022. https://vac4eu.org/covid-19-vaccine-monitoring/. ; World Health Organization. COVID-19 Vaccines: Safety Surveillance Manual, Geneva. 2020. https://www.who.int/docs/default-source/covid-19-vaccines-safety-surveillance-manual/covid19vaccines_manual_aefi_20210104.pdf. ; US Food and Drug Administration. Guidance for Industry: Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment. 2005. ; European Medicines Agency. Guideline on good pharmacovigilance practices (GVP): Product- or Population-Specific Considerations I: Vaccines for prophylaxis against infectious diseases. 2013. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-gvp-product-population-specific-considerations-i-vaccines_en.pdf. ; Black SB, Law B, Chen RT, et al. The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety. Vaccine. 2021;39(19):2712-2718. doi:10.1016/j.vaccine.2021.03.016. ; Gubernot D, Jazwa A, Niu M, et al. U.S. population-based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines. Vaccine. 2021;39(28):3666-3677. doi:10.1016/j.vaccine.2021.05.016. ; Mahaux O, Bauchau V, Van Holle L. Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines. Pharmacoepidemiol Drug Saf. 2016;25(2):215-222. doi:10.1002/pds.3918. ; Lin D-Y, Gu Y, Wheeler B, et al. Effectiveness of COVID-19 vaccines over a 9-month period in North Carolina. N Engl J Med. 2022;386:933-941. doi:10.1056/NEJMoa2117128. ; Self WH, Tenforde MW, Rhoads JP, Gaglani M, Ginde AA, Douin DJ. Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising conditions - United States, march-august 2021. MMWR Morb Mortal Wkly Rep. 2021;70(38):1337-1343. doi:10.15585/mmwr.mm7038e1. ; Centers for Disease Control and Prevention. Selected Adverse Events Reported after COVID-19 Vaccination. 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html. ; Miller ER, McNeil MM, Moro PL, Duffy J, Su JR. The reporting sensitivity of the vaccine adverse event reporting system (VAERS) for anaphylaxis and for Guillain-Barré syndrome. Vaccine. 2020;38(47):7458-7463. doi:10.1016/j.vaccine.2020.09.072. ; Verstraeten T, Baughman AL, Cadwell B, et al. Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination. Am J Epidemiol. 2001;154(11):1006-1012. doi:10.1093/aje/154.11.1006. ; Rosenthal S, Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health. 1995;85(12):1706-1709. doi:10.2105/ajph.85.12.1706. ; Remschmidt C, Wichmann O, Harder T. Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review. BMC Infect Dis. 2015;15(429). doi:10.1186/s12879-015-1154-y. ; Dooling K, Marin M, Wallace M, et al. The advisory committee on immunization Practices' updated interim recommendation for allocation of COVID-19 vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep. 2021;69(5152):1657-1660. ; Xu S, Huang R, Sy LS, et al. COVID-19 vaccination and non-COVID-19 mortality risk - seven integrated health care organizations, United States, December 14, 2020-July 31, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(43):1520-1524. doi:10.15585/mmwr.mm7043e2. ; Bardenheier BH, Gravenstein S, Blackman C, et al. Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents. Vaccine. 2021;39(29):3844-3851. doi:10.1016/j.vaccine.2021.05.088. ; Rosenblum HG, Gee J, Liu R, et al. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe. Lancet Infect Dis. 2022;22(6):802-812. doi:10.1016/S1473-3099(22)00054-8. Contributed Indexing: Keywords: COVID-19; VAERS; death; reports; safety; vaccine Substance Nomenclature: JT2NS6183B (Ad26COVS1) ; 0 (COVID-19 Vaccines) ; 0 (Vaccines) Entry Date(s): Date Created: 20230222 Date Completed: 20230613 Latest Revision: 20240510 Update Code: 20240511

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

Reporting rates for VAERS death reports following COVID-19 vaccination, December 14, 2020-November 17, 2021.